Hovnanian valuation remains attractive, says UBS UBS said Hovnanian's valuation remains attractive following the Q2 report. The analyst remains optimistic on future earnings power and top-line growth. Shares are Buy rated with a $6 price target.
Hovnanian upgraded to Buy from Neutral at Compass Point Compass Point upgraded Hovnanian to Buy given recent underperformance and history of outperformance when the sector bounces. Price target remains $4.50.